Skip to content

CROI: Extended infant nevirapine prophylaxis reduces HIV transmission through breastfeeding

CROI: Pegylated interferon maintenance therapy demonstrates no benefit in HIV/hepatitis C coinfected individuals

CROI: CCR5 antagonist SCH532706 shows potent activity and good tolerability in small trial

CROI: Risk of treatment interruption persists after restarting HAART

CROI: Vicriviroc appears safe and effective at higher doses in treatment-experienced patients after 48 weeks

CROI: Lactobacillus supplementation could help reduce vaginal HIV

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection?

CROI: DAD cohort finds increased risk of heart attack in people taking abacavir or ddI

CROI: Once-daily boosted atazanavir comparable to twice-daily Kaletra in treatment-naive patients, with better lipid profile